Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma
Clinical trial NCT05032820 · COMPLETED
Trial details
- NCT number
- NCT05032820
- Sponsor
- Medical College of Wisconsin
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-05
- Primary completion
- 2024-08-22
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.